Luteolin promotes pathogen resistance in Caenorhabditis elegans via DAF-2/DAF-16 insulin-like signaling pathway
International Immunopharmacology · 2023-02 · 115 · 109679
DOI: 10.1016/j.intimp.2023.109679 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2023-02. Verfasst von Yi Xiao und 8 weiteren Autor:innen. Beteiligte Einrichtung: Guizhou Provincial College-based Key Lab for Tumor Prevention and Treatment with Distinctive Medicines, Zunyi Medical University, Zunyi, Guizhou 5630…. Hauptthemen laut MEDLINE: Caenorhabditis elegans, Caenorhabditis elegans Proteins. Die Arbeit wurde bisher 39-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Institutes of Health.
Abstract (Originalsprache)
The DAF-2/DAF-16 insulin-like signaling pathway was an evolutionarily conserved pathway, which regulated many aspects of organismal physiology, such as pathogen resistance, metabolism, stress response, longevity. Luteolin, a flavone contained in many medical plants and in vegetables, had been shown to exhibit activities such as anti-tumor, anti-oxidant and neuroprotective effects. However, whether the Luteolin influenced the immune response and the underlying molecular mechanisms remained obscure. We found that Luteolin increased resistance to not only the Gram-negative pathogens Pseudomonas aeruginosa and Salmonella enterica but also the Gram-positive pathogens Enterococcus faecalis and Staphylococcus aureus in dose dependent manner. Meanwhile, Luteolin promoted host immune response via inhibiting the growth of pathogenic bacteria. Through the genetic screening in C. elegans, we found that Luteolin promoted innate immunity via DAF-2/DAF-16 insulin-like signaling pathway rather than p38 MAPK pathway and SKN-1. Furthermore, Luteolin activated the DAF-16/FOXO transcription factor for innate immune response. Our work suggested that Luteolin had the potential of improving the patients with pathogen infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guizhou Provincial College-based Key Lab for Tumor Prevention and Treatment with Distinctive Medicines, Zunyi Medical University, Zunyi, Guizhou 563000, China; College of Basic Medicine, Zunyi Medical University, Zunyi,…
Förderung
- National Natural Science Foundation of China
- National Institutes of Health
Zitieren
APA
Xiao, Y., Zhang, L., Zhu, X., Qin, Y., Yu, C., Jiang, N., Li, S., Liu, F., & Liu, Y. (2023). Luteolin promotes pathogen resistance in Caenorhabditis elegans via DAF-2/DAF-16 insulin-like signaling pathway. International Immunopharmacology, 115, 109679. https://doi.org/10.1016/j.intimp.2023.109679
Vancouver
Xiao Y, Zhang L, Zhu X, Qin Y, Yu C, Jiang N, et al. Luteolin promotes pathogen resistance in Caenorhabditis elegans via DAF-2/DAF-16 insulin-like signaling pathway. International Immunopharmacology. 2023;115:109679. doi:10.1016/j.intimp.2023.109679
BibTeX
@article{Xiao2023,
author = {Xiao, Yi and Zhang, Li and Zhu, Xinting and Qin, Ying and Yu, Changyan and Jiang, Nian and Li, Sanhua and Liu, Fang and Liu, Yun},
title = {Luteolin promotes pathogen resistance in Caenorhabditis elegans via DAF-2/DAF-16 insulin-like signaling pathway},
journal = {International Immunopharmacology},
year = {2023},
volume = {115},
pages = {109679},
doi = {10.1016/j.intimp.2023.109679}
}
EUVIMED